在接受化疗的急性白血病儿童中确定中心症状集群和相关物:网络分析
Jia Fang1, Cho-Lee Wong2, Chun-Qin Liu3
1Department of Nursing, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangdong Provincial Clinical Research Center for Child Health, Guangzhou, China.
Frontiers in oncology
|September 6, 2023
概括
胃肠道症状是接受化疗的急性白血病儿童中最主要的症状集群. 解决这些症状对于儿童瘤学的有效管理和护理至关重要.
科学领域:
- 儿科瘤学 儿科瘤学
- 血液学 血液学 血液学
- 症状管理 症状管理
背景情况:
- 关于儿科急性白血病症状集群的先前研究是有限的.
- 关于中心症状集群及其影响因素的知识差距存在.
- 有效的症状管理需要了解这些中心集群和相关因素.
研究的目的:
- 在接受化疗的急性白血病儿童中识别症状集群.
- 探索中心症状集群及其关系.
- 调查与症状集群相关的人口和健康相关因素.
主要方法:
- 从中国招募了586名患有急性白血病的儿童 (2021年1月至2023年4月).
- 使用记忆症状评估尺度10-18用于化疗期间的数据收集.
- 采用主要组件分析用于集群识别和多重线性模型用于因子关联.
主要成果:
- 确定了五个症状集群:口腔/皮肤,体质,自我形象,胃肠道和心理.
- 胃肠道集群成为最核心的症状集群.
- 年龄,性别,临床分类,化疗史和护理人员的教育/婚姻状况与症状严重程度有关.
结论:
- 在化疗期间对患有急性白血病的儿童进行症状集群评估至关重要.
- 优先考虑胃肠道症状管理对于改善患者护理至关重要.
- 这些发现为儿童瘤学中加强症状管理策略提供了信息.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
198
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
198
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
332
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
332
Disorders of Leukocytes
982
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
982
Cancer Survival Analysis
381
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
381


